These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 937869

  • 21. Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
    Huseman CA, Hassing JM, Sibilia MG.
    J Clin Endocrinol Metab; 1986 Mar; 62(3):484-90. PubMed ID: 3080463
    [Abstract] [Full Text] [Related]

  • 22. [Behavior of HGH after oral administration of L-dopa in normal and obese subjects].
    Carducci Artenisio A, Ragonese F, Albanese MC, Alibrando S, Allegra V.
    Boll Soc Ital Biol Sper; 1974 Aug 30; 50(13):946-52. PubMed ID: 4463984
    [No Abstract] [Full Text] [Related]

  • 23. [Amantadine potentiation of G.H. relase evoked by L-dopa and its inhibition by nonesterified fatty acids].
    Cabezas-Cerrato J, Casanueva Freijo F, Villanueva Aranguren L, Avila C, Fernández-Cruz A.
    Rev Clin Esp; 1977 May 15; 145(3):165-8. PubMed ID: 866739
    [No Abstract] [Full Text] [Related]

  • 24. Sequential use of insulin and levodopa to provoke pituitary secretion of growth hormone.
    Reiter EO, Root AW, Duckett GE.
    Am J Dis Child; 1977 Feb 15; 131(2):189-91. PubMed ID: 835536
    [Abstract] [Full Text] [Related]

  • 25. [Carbidopa-levodopa, growth hormone and parkinsonism].
    Marti-Masso JF, Carrera N, Martínez-Lage JM.
    Rev Clin Esp; 1976 Jun 30; 141(6):525-32. PubMed ID: 968087
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment with hGH. Factors influencing response in children with somatotrophic insufficiency (author's transl)].
    Kurtz F, Mugnier E, Roy MP, Rappaport R.
    Arch Fr Pediatr; 1981 Jun 30; 38(6):405-9. PubMed ID: 7294958
    [Abstract] [Full Text] [Related]

  • 27. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
    Maeda K, Kato Y, Chihara K, Ogo S, Iwasaki Y.
    J Clin Endocrinol Metab; 1975 Aug 30; 41(2):408-11. PubMed ID: 239963
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Somatropin secretion in chronic alcoholism: lack of response to stimulation with L-dopa and glucagon].
    Riesco J, Costamaillere L, Litvak J, Zlatar N.
    Rev Med Chil; 1974 Jun 30; 102(6):443-6. PubMed ID: 4471413
    [No Abstract] [Full Text] [Related]

  • 30. Effect of levodopa (L-dopa) on serum growth hormone in children with short stature.
    Chakmakjian ZH, Marks JF, Fink CW.
    Pediatr Res; 1973 Feb 30; 7(2):71-4. PubMed ID: 4688499
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Simplified test of stimulation of immunoreactive growth hormone (HGH-IR) by L-dopa: value as a screening test].
    Ruitton A, Locard E, David M, Longin B.
    Arch Fr Pediatr; 1973 Feb 30; 30(7):725-33. PubMed ID: 4780665
    [No Abstract] [Full Text] [Related]

  • 33. [Effects of oral administration of L-dopa on the secretion of plasma growth hormone in subjects of pediatric age].
    Rigillo N, Dammacco F, Pentasuglia N, Zimbalatti F.
    Minerva Pediatr; 1975 Apr 28; 27(15):908-14. PubMed ID: 1134455
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. L-dopa restores amplitude of growth hormone pulses in old male rats to that observed in young male rats.
    Sonntag WE, Forman LJ, Miki N, Trapp JM, Gottschall PE, Meites J.
    Neuroendocrinology; 1982 Mar 28; 34(3):163-8. PubMed ID: 6122169
    [Abstract] [Full Text] [Related]

  • 37. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M, Jurcovicová J, Németh S, Vigas M.
    Endocrinol Exp; 1988 Dec 28; 22(4):243-8. PubMed ID: 3243205
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evaluation of propranolol-glucagon test.
    Okada Y, Watanabe K, Takeuchi T, Hata T, Mikam H.
    Acta Endocrinol (Copenh); 1977 Oct 28; 86(2):243-50. PubMed ID: 578617
    [Abstract] [Full Text] [Related]

  • 40. The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients.
    Dobrew D, Zonew I, Milanow S.
    Ther Hung; 1977 Oct 28; 25(4):145-9. PubMed ID: 605413
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.